58k+ listingsShips to NLResponse within one hour+31 73 711 4717info@questpair.com

Varian Cary Eclipse

This model was found in 882 unique locations in 53 countries, where it was mentioned from 1999 until recently.

  • spectrofluorometer
  • fluorescence
  • luminescence spectrometer
  • fluorescence spectrophotometer
locations where this model was found
882
countries where the model is used
53
related research fields
144
first year this model was mentioned
1999

About the Varian Cary Eclipse

Questpair Analytics found the Varian Cary Eclipse at 882 research organisations and laboratories in 53 countries, in publications from 1999 until recently. It is used most in Biochemistry, Molecular Biology and Organic Chemistry.

Usage over time

Mentions per year, 1999–2020

2020 has the most mentions so far.

Research fields

144 related research fields

The Varian Cary Eclipse is used by scientists in research fields such as Biochemistry, Molecular Biology, Organic Chemistry, General Chemistry and Physical and Theoretical Chemistry.

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • General Chemistry
  • Physical and Theoretical Chemistry
  • General Medicine
  • Molecular Medicine
  • General Materials Science
  • Analytical Chemistry
  • Pharmaceutical Science
  • Drug Discovery
  • Spectroscopy
  • General Physics and Astronomy
  • Catalysis
  • General Biochemistry, Genetics and Molecular Biology
  • Inorganic Chemistry
  • Cell Biology
  • Bioengineering
  • Biophysics
  • Biotechnology
  • General Chemical Engineering
  • Pharmacology
  • Chemistry (miscellaneous)
  • Computer Science Applications
  • Structural Biology
  • Condensed Matter Physics
  • Microbiology
  • Biomedical Engineering
  • Clinical Biochemistry
  • Surfaces and Interfaces
  • + 114 more

Organisations using this equipment

The model was found at 882 locations in 53 countries.

882 locations in 53 countries
OrganisationInstrumentCityCountry
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry
Varian Cary Eclipse FluorescenceMoscowRussia
Indian Institute of Technology Delhi
Varian Cary Eclipse FluorescenceNew DelhiIndia
University of Ulster
Varian Cary Eclipse FluorescenceColeraineUnited Kingdom
University of Limerick
Varian Cary Eclipse FluorescenceLuimneachIreland
University of Groningen
Varian Cary Eclipse FluorescenceGroningenNetherlands
University of Wales
Varian Cary Eclipse FluorescenceCardiffUnited Kingdom
7–12 of 882

Research that uses the Varian Cary Eclipse

Only abstracts that are published under Creative Commons Attribution 4.0 are shown on this page.

Feasibility Study of an Alcohol-Based Liquid Scintillation Detector and Its Application

This paper proposes a new base material, a mixture of alcohol and water, for liquid scintillators. A possibility of using alcohol as a new detection solution in a particle detector is described. A liquid scintillator is widely used in various fields because of its high light yield. In addition, it is very important to develop a stable liquid scintillator for particle detectors or other medical applications. To date, there have been no previous R&D studies elsewhere for the use of alcohol in particle detectors, and no market products are available of this type. Thus, there is a room for improvement. This paper describes the brief synthesizing process of the alcohol-based liquid scintillator by varying the mixing ratio of each component that makes up the liquid scintillator. The several feasible physical and optical properties of an alcohol-based liquid scintillator were investigated and presented. Finally, as one of its applications, a range (beam-path length) measurement using an electron beam in medical physics is introduced after irradiating an alcohol-based liquid scintillator with electron beam energies of 6~12 MeV. The measurement results were compared with a Monte Carlo simulation, Novalis Tx, a phantom, and a CT image. In the near future, the new alcohol-based liquid scintillator could be used for particle detector or medical imaging applications.

Byoung Chan Kim, Ji Young Choi, Kyung Kwang Joo, Seon Yeong Park, Ye Sung Song, Hee Jin Woo. Advances in High Energy Physics, 2021, 1-10, 2021.

Read the publication
Spectroscopic Investigation of Chlorin-Based Photosensitizers in Polymer Matrix

Chlorin e6 and its derivatives are the basis of a number of drugs used in medicine in the treatment of various diseases, including cancer, by photodynamic therapy. Nonpolar derivatives of Chlorin e6—dimethyl ether of Chlorin e6 (DME Ce6) and trimethyl ether of Chlorin e6 (TME Ce6)—are actively studied for application during photodynamic therapy. In this work, based on the electron optical absorption spectra, the interaction of photosensitizer molecules with branched star-like copolymer dextran-graft-polyacrylamide in anionic form was investigated and the possibility of using the latter as a carrier for drug delivery to tumor cells was suggested.

Antonina Naumenko, Nataliya Kutsevol. International Journal of Polymer Science, 2021, 1-7, 2021.

Read the publication
Janus-type dual emission of a Cyclometalated Iron(III) complex

Photoactive compounds are essential for photocatalytic and luminescent applications, such as photoredox catalysis or light emitting diodes. However, the substitution of noble metals, which are almost exclusively used, by base metals remains a major challenge on the way to a more sustainable world.1 Iron is a dream candidate for this ambitious aim.2 But compared to noble metal complexes that show long-lived metal-to-ligand charge-transfer (MLCT) states, realization of emissive and photoactive iron complexes is demanding, due to the fast deactivation of charge transfer states into non-emissive inactive states. No MLCT emission has been observed for monometallic iron complexes before. Consequently, dual emission could also not yet be realized with iron complexes, as it is a very rare property even of noble metal compounds. Here we report the FeIII complex [Fe(ImP)2][PF6] (HImP = 1,1’-(1,3-phenylene)bis(3-methyl-1-imidazol-2-ylidene)), showing Janus-type dual emission by combining LMCT (ligand-to-metal charge transfer) with MLCT luminescence. The respective excited states are characterized by a record lifetime of τMLCT = 4.2 ns, and a moderate τLMCT = 0.2 ns. Only two emissive FeIII compounds are known so far and they show LMCT luminescence only.3,4 The unique properties of the presented complex are caused by the specific ligand design combining four N-heterocyclic carbenes with two cyclometalating groups, using the σ-donor strength of six carbon atoms and the acceptor capabilities of the central phenyl rings. Spectroscopically, doublet manifolds could be identified in the deactivation process, while (TD)DFT analysis revealed the presence of quartets as well. With three key advancements of realizing the first iron complex showing dual luminescence, a MLCT luminescence and a world record MLCT lifetime, the results constitute a basis for future application of iron complexes as white light emitters and new photocatalytic reactions making use of the Janus-type properties of the developed complex.

Matthias Bauer, Jakob Steube, Ayla Päpcke, Olga Bokareva, Thomas Reuter, Serhiy Demeshko, Roland Schoch, Stephan Hohloch, Franc Meyer, Katja Heinze, Oliver Kühn, Stefan Lochbrunner. 2020.

Read the publication
Amyloid precipitation in biofluids using a structure-specific chemical antibody

The composition of soluble toxic protein aggregates formed in vivo is currently unknown in neurodegenerative diseases, due to their ultra-low concentration in human biofluids and their high degree of heterogeneity. We introduce the structure-specific chemical antibody; a Y shaped, bioinspired small molecule with a dimeric region to mimic avidity, and an attachment region to mimic the Fc region. Our probe, capture molecule for amyloid precipitation (CAP-1), consists of a derivative of Pittsburgh compound B (dimer) to target the cross β-sheets of amyloids and a biotin moiety for surface immobilization. By coupling CAP-1 to magnetic beads, we targeted the amyloid structure of protein aggregates in human cerebrospinal fluid, isolated them for analysis and then characterised them using single-molecule fluorescence imaging and mass spectrometry. AP allows unbiased determination of the molecular composition and structural features of the in vivo aggregates, formed in neurodegenerative diseases, that are present in biofluids.

Margarida Rodrigues, Payel Bhattacharjee, Ann Brinkmalm, Dung Do, Colin Pearson, Suman De, Aleks Ponjavic, Juan Varela, Francesco Ruggeri, Isabelle Baudrexel, Ji Lee, Alexander Carr, Klara Kulenkampff, Tuomas Knowles, Henrik Zetterberg, Thomas Snaddon, Sonia Gandhi, Steven Lee, David Klenerman. 2020.

Read the publication
Mechanistic insights into the protective roles of polyphosphate against amyloid cytotoxicity

The universally abundant polyphosphate (polyP) accelerates fibril formation of disease-related amyloids and protects against amyloid cytotoxicity. To gain insights into the mechanism(s) by which polyP exerts these effects, we focused on α-synuclein, a well-studied amyloid protein, which constitutes the major component of Lewy bodies found in Parkinson’s disease. Here, we demonstrate that polyP is unable to accelerate the rate-limiting step of α-synuclein fibril formation but effectively nucleates fibril assembly once α-synuclein oligomers are formed. Binding of polyP to α-synuclein either during fibril formation or upon fibril maturation substantially alters fibril morphology and effectively reduces the ability of α-synuclein fibrils to interact with cell membranes. The effect of polyP appears to be α-synuclein fibril specific and successfully prevents the uptake of fibrils into neuronal cells. These results suggest that altering the polyP levels in the extracellular space might be a potential therapeutic strategy to prevent the spreading of the disease.

Justine Lempart, Eric Tse, James A Lauer, Magdalena I Ivanova, Alexandra Sutter, Nicholas Yoo, Philipp Huettemann, Daniel Southworth, Ursula Jakob. Life Science Alliance, 2 (5), e201900486, 2019.

Read the publication
A Novel Photosensitizer for Lipid Droplet–Location Photodynamic Therapy

Lipid droplets (LDs), an extremely important cellular organelle, are responsible for the storage of neutral lipids in multiple biological processes, which could be a potential target site for photodynamic therapy (PDT) of cancer. Herein, a lipid droplet–targeted photosensitizer (BODSeI) is developed, allowing for fluorescence imaging–guided PDT. Owing to the location of lipid droplets, BODSeI demonstrates enhanced PDT efficiency with an extremely low IC50 value (around 125 nM). Besides, BODSeI shows good biocompatibility and high photostability. Therefore, BODSeI is promising for droplet-location PDT, which may trigger wide interest for exploring the pathway of lipid droplet–location PDT.

Xiang Xia, Ran Wang, Yingqi Hu, WeiJian Liu, Ting Liu, Wen Sun, Jiangli Fan, Xiaojun Peng. Frontiers in Chemistry, 9, 2021.

Read the publication
Cell-Free DNA Promotes Thrombin Autolysis and Generation of Thrombin-Derived C-Terminal Fragments

Cell-free DNA (cfDNA) is the major structural component of neutrophil extracellular traps (NETs), an innate immune response to infection. Antimicrobial proteins and peptides bound to cfDNA play a critical role in the bactericidal property of NETs. Recent studies have shown that NETs have procoagulant activity, wherein cfDNA triggers thrombin generation through activation of the intrinsic pathway of coagulation. We have recently shown that thrombin binds to NETs in vitro and consequently can alter the proteome of NETs. However, the effect of NETs on thrombin is still unknown. In this study, we report that DNA binding leads to thrombin autolysis and generation of multiple thrombin-derived C-terminal peptides (TCPs) in vitro. Employing a 25-residue prototypic TCP, GKY25 (GKYGFYTHVFRLKKWIQKVIDQFGE), we show that TCPs bind NETs, thus conferring mutual protection against nuclease and protease degradation. Together, our results demonstrate the complex interplay between coagulation, NET formation, and thrombin cleavage and identify a previously undisclosed mechanism for formation of TCPs.

Rathi Saravanan, Yeu Khai Choong, Chun Hwee Lim, Li Ming Lim, Jitka Petrlova, Artur Schmidtchen. Frontiers in Immunology, 12, 2021.

Read the publication

About Questpair Analytics

Questpair Analytics inventorises the usage of scientific equipment such as the Varian Cary Eclipse in research organisations and laboratories around the world. Our goal is to make it easier for professionals in research and industry to discover the availability and use cases for specific types of laboratory equipment.

We also identify locations where different brands and models are used, which we believe can help to facilitate a more efficient and circular usage of existing instruments. For example, researchers and makers can use our services to find the necessary equipment that is required to complete a specific research purpose or to analyze or create advanced materials.

Explore Questpair Analytics

Disclaimer: The data on this site is intended for educational purposes only. QuestPair assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided and presented on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness.

We find the unfindable